KarmelSonix is a dynamic young company built on a solid foundation of clinical expertise. A global leader in developing acoustic respiratory monitoring devices, the Company’s ground breaking products are based on acoustic signal acquisition technology and advanced analysis capabilities.

KarmelSonix’s proprietary technology responds to an unmet need for accurate, low cost, easy-to-use devices to identify and quantify the presence of wheezes.

The Company is focused on pulmonary acoustics as diagnostic and monitoring tools for managing asthma.

Asthma management requires definite diagnosis, accurate assessment of control, and long term follow up. With KarmelSonix technology it is possible, for the first time, to do so without the need for extensive patient cooperation. Automatic wheeze, cough and breathing detection facilitate quantitative, objective and noninvasive assessment of asthma activity for all ages and around the clock. It optimizes patient care in individuals such as young children, as well as the elderly, and in scenarios where spirometry is not feasible.

Read more...